Recent Breakthrough in 68Ga-Radiopharmaceuticals Cold Kits for Convenient PET Radiopharmacy
D Satpati - Bioconjugate Chemistry, 2021 - ACS Publications
68Ga-PET has emerged as an important diagnostic tool for precise detection and monitoring
of oncological situations. Availability, cost, and radiosynthesis procedure are determining …
of oncological situations. Availability, cost, and radiosynthesis procedure are determining …
Clinical applications of radiolabeled peptides for PET
Radiolabeled peptides are a valuable class of radiotracer that occupies the space between
small molecules and large biologics, and are able to exploit the advantages of both classes …
small molecules and large biologics, and are able to exploit the advantages of both classes …
68Ga/177Lu-NeoBOMB1, a novel radiolabeled GRPR antagonist for theranostic use in oncology
SU Dalm, IL Bakker, E de Blois… - Journal of Nuclear …, 2017 - Soc Nuclear Med
Because overexpression of the gastrin-releasing peptide receptor (GRPR) has been
reported on various cancer types, for example, prostate cancer and breast cancer, targeting …
reported on various cancer types, for example, prostate cancer and breast cancer, targeting …
From bench to bed: New gastrin-releasing peptide receptor-directed radioligands and their use in prostate cancer
T Maina, BA Nock - PET clinics, 2017 - pet.theclinics.com
The gastrin-releasing peptide receptor (GRPR) has been widely regarded as an attractive
molecular target for tumor diagnosis and therapy with radiolabeled peptide analogs, owing …
molecular target for tumor diagnosis and therapy with radiolabeled peptide analogs, owing …